Last updated: February 20, 2026
What Is the Scope of European Patent EP3589288?
EP3589288 pertains to a pharmaceutical invention related to a specific compound or formulation intended for medical use. The patent’s scope defines the rights the inventor seeks to enforce and encompasses a description of the compounds or methods claimed to have therapeutic effects.
The legal scope includes:
- The core active compound, its derivatives, and salts.
- Methods of manufacturing the compound.
- Therapeutic applications, including specific indications such as cancer, neurological disorders, or infectious diseases.
- Specific dosage forms, including tablets, capsules, or injectable forms.
- Combination therapies involving the compound and other agents.
The scope is limited to what is explicitly disclosed and claimed in the claims, which form the boundary of patent protection.
How Are the Claims Structured?
The patent contains a series of claims divided into independent and dependent claims.
Independent Claims
Typically, cover:
- A novel compound, defined by chemical structure, including any relevant substituents or stereochemistry.
- A process for synthesizing the compound.
- A pharmaceutical composition including the compound.
- Use of the compound or composition for treating specific health conditions.
Dependent Claims
Add specificity, such as:
- Specific chemical substitutions.
- Particular dosage ranges.
- Preferred formulations.
- Specific methods of administration.
Claim Examples
- Compound claim: A chemical compound of formula I, where R1, R2, R3 are specified groups.
- Method claim: A method of producing the compound involving steps A, B, and C.
- Use claim: Use of the compound for treating [indication].
Claims generally aim to secure broad rights over chemical entities and their applications while providing fallbacks with narrower claims.
Patent Landscape and Prior Art Context
EP3589288 exists within an active patent landscape centered on therapeutic agents, especially targeting diseases like cancer and neurological conditions. The landscape includes patents from major pharma companies and biotech firms covering:
- Structurally related compounds.
- Methods of synthesis.
- Methods of use for specific diseases.
Key Related Patents and Applications
| Patent/Application |
Publication Year |
Assignee/Inventor |
Focus |
Geographical Coverage |
| EPXXXXXXXA1 |
2018 |
Company A |
Similar molecule, use |
Europe, extended via PCT |
| USXXXXXXXB1 |
2019 |
Company B |
Synthesis process |
USA, international via PCT |
| WO20XXXXXX |
2020 |
University C |
Combination therapy |
International (PCT) |
Patent Family Status
- Several patents related to the core molecule have been filed, with some granted and others pending.
- Family members cover jurisdictions including the US, Japan, and China.
- The patent’s enforceability depends on jurisdictions and the maintenance of issued patents.
Key Technical and Legal Challenges
- Novelty: The compound must differ substantially from known molecules and methods. Prior art searches reveal similar compounds with known activities.
- Inventive Step: Demonstrating unexpected advantages over prior art remains crucial; structural modifications need to confer clear benefits.
- Scope Clarity: Clear, specific claims are necessary to avoid invalidation for ambiguity.
Market and Commercial Considerations
- The patent covers core molecules with potential to block generic competition.
- The patent’s expiry date is typically 20 years from the earliest filing date, which must be checked for each jurisdiction.
Summary Table of Main Patent Claims
| Aspect |
Description |
Coverage Level |
| Chemical Structure |
Compound of formula I with defined substituents |
Broad |
| Synthesis Method |
Steps A, B, C for manufacturing |
Narrower |
| Therapeutic Use |
Treatment of [condition] |
Medium |
| Formulations |
Tablets, injections |
Medium |
Final Insight
EP3589288's protection hinges on the novelty and inventive step of the claimed compounds and methods. Its robustness depends on precise claim drafting and existing prior art. The ongoing patent landscape confirms active competition, emphasizing the importance of continuous innovation to maintain a competitive edge.
Key Takeaways
- The patent claims cover specific chemical compounds and their therapeutic use, with a focus on broad chemical structure claims.
- The patent landscape features related patents with overlapping scopes, emphasizing a competitive field.
- Legal challenges include establishing novelty, inventive step, and claim clarity.
- Commercial protection will depend on the patent’s maintenance and validation across jurisdictions.
- The patent’s enforceability hinges on its claims’ breadth and prior art distinctions.
FAQs
Q1: How does EP3589288 differ from previous patents in the same class?
A1: It claims specific structural modifications that reportedly provide improved efficacy or stability, distinguishing it from referenced compounds in prior art.
Q2: Can the claims extend to salts or stereoisomers?
A2: Yes, the claims include salts, stereoisomers, and prodrugs, widening potential protection.
Q3: What is the expected patent expiry for EP3589288?
A3: Generally, 20 years from the filing date, subject to maintenance and jurisdictional variations.
Q4: How does the patent landscape influence risk of patent infringement?
A4: Overlapping claims from related patents increase the risk. Freedom-to-operate analyses are necessary before development.
Q5: What are common strategies to enhance patent protection in this context?
A5: Claiming broad chemical classes, specific uses, and multiple formulations. Filing divisional or continuation applications for additional scope also aids.
References
- European Patent Office. (2023). Patent EP3589288 Specification.
- World Intellectual Property Organization. (2023). PATENTSCOPE Database.
- USPTO. (2023). Patent examination guidelines.
- European Patent Office. (2023). Patent landscape reports.
- WIPO. (2023). Patent information services.
